FDA Inspection
AptaPharma Inc.AptaPharma Inc. – FDA Inspection, Sep 25, 2019
Record Details
This FDA Inspection record concerns AptaPharma Inc., with an inspection on September 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 412628c1-3ed7-4ab7-afc9-0f5453b9d583
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1102699
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of AptaPharma Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | VAI | New Jersey District Office | Drug Quality Assurance |
| October 24, 2024 | Not classified | New Jersey District Office | |
| May 15, 2023 | Not classified | New Jersey District Office | |
| March 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AptaPharma Inc.
- FDA Inspection 1331256 - 2026-08-14
- FDA Inspection 1231140 - 2024-10-24
- FDA Inspection 1205203 - 2023-05-15
- FDA Inspection 1045668 - 2018-03-16
- FDA Inspection 884304 - 2014-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.